Medical Cardiologist Sergiu Darabant, M.D., joins Miami Cardiac & Vascular Institute
“We’d like to welcome Dr. Darabant to Miami Cardiac & Vascular Institute,” said Jonathon Fialkow, M.D., deputy director of the Institute, chief of cardiology and co-medical director of the lipid management program. “His vast experience as a medial cardiologist and specialized training in transthoracic and transesophageal echocardiography will make him an excellent addition to our team.”
Dr. Darabant joins Miami Cardiac & Vascular Institute from the University of Louisville Hospital in Louisville, Kentucky. Under the mentorship of Dr. Marcus Stoddard, the president of the National Board of Echocardiography, he developed a special interest and training in transthoracic and transesophageal echocardiography imaging modalities. These techniques are used in evaluating cardiovascular disease and stroke patients. When used, the imaging is included as preprocedural evaluation of valvular heart disease, preparation for structural heart disease interventions and medical guidance to prevent recurring stroke.
His research has been published in peer-reviewed journals, including the New England Journal of Medicine, the Journal of Heart Valve Disease, the Journal of Hospital Medicine and ACC FIT Online. Dr. Darabant also was elected as an American College of Cardiology Fellow in Training (FIT) Editorial Fellow.
Dr. Darabant earned his medical degree from Iuliu Hatieganu University of Medicine and Pharmacy. He completed his internal medicine residency at the University of New Mexico Health Sciences Center and cardiovascular disease fellowship at the University of Louisville Hospital, where he served as chief fellow.
Dr. Darabant is part of the Miami Cardiac & Vascular Institute’s Cardiology Group. The team is composed of the most accomplished and respected professionals in their field. These top-tier physicians, advanced practice providers, medical assistants and clinical pharmacists work hand in hand to create a personalized approach for each and every patient. Because the cardiologists have expertise in a vast array of cardiology specialties, including advanced heart failure, cardio-oncology, clinical lipidology, resistant hypertension, vascular medicine and — coming soon — sports cardiology, they can focus on treating specific heart conditions with innovative solutions.
He will see patients at two Miami Cardiac & Vascular Institute locations: 7400 SW 87 Avenue, Suite 100, in Kendall, and 13101 S. Dixie Hwy, Suite 420 in Pinecrest.
About Miami Cardiac & Vascular Institute
Miami Cardiac & Vascular Institute is the largest and most comprehensive cardiovascular facility in the region. The team of multilingual, multidisciplinary specialists pioneered the development of minimally invasive techniques used to treat aneurysms, blockages in veins and arteries and holes in the heart. The Institute leverages the power of Baptist Health’s combined resources of experts, pioneering research, compassionate caregivers and leading-edge treatments and technology.
Miami Cardiac & Vascular Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with 11 hospitals, more than 23,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.
# # #
